Click
here to close Hello! We notice that
you are using Internet Explorer, which is not supported by Echinobase
and may cause the site to display incorrectly. We suggest using a
current version of Chrome,
FireFox,
or Safari.
Oxid Med Cell Longev
2013 Jan 01;2013:609019. doi: 10.1155/2013/609019.
Show Gene links
Show Anatomy links
Mild systemic oxidative stress in the subclinical stage of Alzheimer''s disease.
Giavarotti L
,
Simon KA
,
Azzalis LA
,
Fonseca FL
,
Lima AF
,
Freitas MC
,
Brunialti MK
,
Salomão R
,
Moscardi AA
,
Montaño MB
,
Ramos LR
,
Junqueira VB
.
???displayArticle.abstract???
Alzheimer''s disease (AD) is a late-onset, progressive degenerative disorder that affects mainly the judgment, emotional stability, and memory domains. AD is the outcome of a complex interaction among several factors which are not fully understood yet; nevertheless, it is clear that oxidative stress and inflammatory pathways are among these factors. 65 elderly subjects (42 cognitively intact and 23 with probable Alzheimer''s disease) were selected for this study. We evaluated erythrocyte activities of superoxide dismutase, catalase, and glutathione peroxidase as well as plasma levels of total glutathione, α-tocopherol, β-carotene, lycopene, and coenzyme Q10. These antioxidant parameters were confronted with plasmatic levels of protein and lipid oxidation products. Additionally, we measured basal expression of monocyte HLA-DR and CD-11b, as well as monocyte production of cytokines IL1-α, IL-6, and TNF-α. AD patients presented lower plasmatic levels of α-tocopherol when compared to control ones and also higher basal monocyte HLA-DR expression associated with higher IL-1α production when stimulated by LPS. These findings support the inflammatory theory of AD and point out that this disease is associated with a higher basal activation of circulating monocytes that may be a result of α-tocopherol stock depletion.
Figure 1. Representative flow cytometric analysis of whole blood samples stained with anti-CD11b-APC (right column) and anti-HLA-DR-PE (left column) monoclonal antibodies. From all events acquired in gate R1 (upper left graph), CD14-positive monocytes (gate R2, separated from CD66b-positive neutrophils in gate R3; upper right graph) were used for histogram calculation of the geometric mean fluorescence intensity (GMFI). A similar analysis was performed for the detection of fluorescent DCF in the ROS assay (histogram not shown). INT (sample from cognitively intact patient) and AD (sample from patient with probable Alzheimer's disease).
Figure 2. Representative flow cytometric detection of monocyte intracellular production of IL-1α, IL-6, and TNF-α. Monocytes were selected in a similar manner as described in Figure 1. LPS-induced production of each cytokine was determined by the percentage of events in the upper right quadrant (%URQ). Only upper quadrants are shown. INT (sample from cognitively intact patient) and AD (sample from patient with probable Alzheimer's disease).
Azzi,
The role of alpha-tocopherol in preventing disease: from epidemiology to molecular events.
2003, Pubmed
Azzi,
The role of alpha-tocopherol in preventing disease: from epidemiology to molecular events.
2003,
Pubmed
Behl,
Antioxidant neuroprotection in Alzheimer's disease as preventive and therapeutic approach.
2002,
Pubmed
Beloosesky,
Cytokine levels and phagocytic activity in patients with Alzheimer's disease.
2002,
Pubmed
Brunialti,
Influence of EDTA and heparin on lipopolysaccharide binding and cell activation, evaluated at single-cell level in whole blood.
2002,
Pubmed
Bulger,
An argument for Vitamin E supplementation in the management of systemic inflammatory response syndrome.
2003,
Pubmed
Buss,
Protein carbonyl measurement by a sensitive ELISA method.
1997,
Pubmed
Casal,
Serum markers of monocyte/macrophage activation in patients with Alzheimer's disease and other types of dementia.
2003,
Pubmed
Chan,
Alpha-tocopherol modulates tyrosine phosphorylation in human neutrophils by inhibition of protein kinase C activity and activation of tyrosine phosphatases.
2001,
Pubmed
Choi,
Identification of oxidized plasma proteins in Alzheimer's disease.
2002,
Pubmed
Combs,
beta-Amyloid stimulation of microglia and monocytes results in TNFalpha-dependent expression of inducible nitric oxide synthase and neuronal apoptosis.
2001,
Pubmed
Conrad,
Oxidized proteins in Alzheimer's plasma.
2000,
Pubmed
D'Andrea,
The microglial phagocytic role with specific plaque types in the Alzheimer disease brain.
2004,
Pubmed
Dickerson,
The cortical signature of Alzheimer's disease: regionally specific cortical thinning relates to symptom severity in very mild to mild AD dementia and is detectable in asymptomatic amyloid-positive individuals.
2009,
Pubmed
Esposito,
A review of specific dietary antioxidants and the effects on biochemical mechanisms related to neurodegenerative processes.
2002,
Pubmed
Folstein,
"Mini-mental state". A practical method for grading the cognitive state of patients for the clinician.
1975,
Pubmed
Hasui,
Simultaneous measurement by flow cytometry of phagocytosis and hydrogen peroxide production of neutrophils in whole blood.
1989,
Pubmed
Heseker,
Requirement and supply of vitamin C, E and beta-carotene for elderly men and women.
1994,
Pubmed
Jana,
Fibrillar amyloid-beta peptides kill human primary neurons via NADPH oxidase-mediated activation of neutral sphingomyelinase. Implications for Alzheimer's disease.
2004,
Pubmed
Jomova,
Metals, oxidative stress and neurodegenerative disorders.
2010,
Pubmed
Junqueira,
Aging and oxidative stress.
2004,
Pubmed
Kusdra,
Elevation of CD69+ monocyte/macrophages in patients with Alzheimer's disease.
2000,
Pubmed
Mecocci,
Lymphocyte oxidative DNA damage and plasma antioxidants in Alzheimer disease.
2002,
Pubmed
Montaño,
[Validity of the Portuguese version of Clinical Dementia Rating].
2005,
Pubmed
Morris,
The Clinical Dementia Rating (CDR): current version and scoring rules.
1993,
Pubmed
Polidori,
Plasma antioxidant status, immunoglobulin g oxidation and lipid peroxidation in demented patients: relevance to Alzheimer disease and vascular dementia.
2004,
Pubmed
Rojo,
Neuroinflammation: implications for the pathogenesis and molecular diagnosis of Alzheimer's disease.
2008,
Pubmed
Sano,
Do dietary antioxidants prevent Alzheimer's disease?
2002,
Pubmed
Shalit,
Elevated interleukin-6 secretion levels by mononuclear cells of Alzheimer's patients.
1994,
Pubmed
Tietze,
Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissues.
1969,
Pubmed
Viña,
Molecular bases of the treatment of Alzheimer's disease with antioxidants: prevention of oxidative stress.
2004,
Pubmed
Wegiel,
Origin and turnover of microglial cells in fibrillar plaques of APPsw transgenic mice.
2003,
Pubmed
Zandi,
Reduced risk of Alzheimer disease in users of antioxidant vitamin supplements: the Cache County Study.
2004,
Pubmed
Zotova,
Inflammation in Alzheimer's disease: relevance to pathogenesis and therapy.
2010,
Pubmed
